pyrazines has been researched along with Experimental Mammary Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gartel, AL; Halasi, M; Hay, N; Nogueira, V; Pandit, B; Wang, M | 1 |
| Celis, E; Lee, S; Sayers, TJ; Yagita, H | 1 |
| Brown, E; Buck, E; Chiu, MI; Epstein, D; Eyzaguirre, A; Gokhale, PC; Koujak, S; Lerner, L; Miglarese, MR; Pachter, JA; Rosenfeld-Franklin, M; Tao, N; Wild, R | 1 |
| Demaria, S; Formenti, SC; Liebes, L; Ng, B; Santori, FR; Vukmanovic, S | 1 |
| Kiselyov, A | 1 |
| Chimirri, A; Fenech, G; Grasso, S; Monforte, P | 1 |
| Adams, J; Ara, G; Herbst, R; Palombella, VJ; Teicher, BA | 1 |
| Ansher, SS; Bueding, E; Dolan, P | 1 |
| Bloch, A; Bobek, M; Cole, FE; Sharma, RA | 1 |
9 other study(ies) available for pyrazines and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Administration Schedule; Estradiol; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Humans; Isothiocyanates; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Oxidative Stress; Pyrazines; Random Allocation; Reactive Oxygen Species; RNA Interference; Transplantation, Heterologous; Treatment Outcome | 2013 |
Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Synergism; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oligodeoxyribonucleotides; Pyrazines; Rats; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Toll-Like Receptor 9; Treatment Outcome | 2010 |
Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Imidazoles; Mammary Neoplasms, Experimental; Mice; Phosphorylation; Polymerase Chain Reaction; Pyrazines; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction | 2010 |
Select forms of tumor cell apoptosis induce dendritic cell maturation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Dendritic Cells; fas Receptor; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Pyrazines; Signal Transduction; Tamoxifen | 2005 |
Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Cancer mouse models and other techniques for improved prediction of efficacy.
Topics: Angiogenesis Inhibitors; Animals; Boronic Acids; Bortezomib; Camptothecin; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Forecasting; Gemcitabine; Green Fluorescent Proteins; Humans; Image Enhancement; Irinotecan; Luminescent Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Pyrazines; Red Fluorescent Protein; Technology, Pharmaceutical; Treatment Outcome | 2005 |
[Compounds with presumable antitumor activity. III. 1-Substituted N,N'-di-2-pyrimidinyl (or pyrazinyl)methylenediamine].
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Diamines; Female; Leukemia L1210; Leukemia P388; Mammary Neoplasms, Experimental; Melanoma; Mice; Ovarian Neoplasms; Pyrazines; Pyrimidines; Rats | 1984 |
The proteasome inhibitor PS-341 in cancer therapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dipeptides; Drug Synergism; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pyrazines; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Ubiquitins | 1999 |
Biochemical effects of dithiolthiones.
Topics: Animal Feed; Animals; Brassica; Butylated Hydroxyanisole; Female; Glutathione; Glutathione Transferase; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Pyrazines; Rats; Rats, Inbred F344; Structure-Activity Relationship; Thiones; Thiophenes | 1986 |
Synthesis and biological activity of some imidazo(4,5-b)pyrazines and their ribonucleosides as purine analogs.
Topics: Animals; Burkitt Lymphoma; Cells; Cells, Cultured; Crystallography; Escherichia coli; Imidazoles; Inosine; Leukemia L1210; Mammary Neoplasms, Experimental; Methods; Mice; Oxides; Purines; Pyrazines; Ribonucleosides; Xanthine Oxidase | 1973 |